Approval · Notice of Compliance 1008 · 2000
IMMUCYST: Notice of Compliance 1008
Issued March 17, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1008
- Date
- March 17, 2000
- Company
- Aventis Pasteur LimitedSwiftwater, Pennsylvania, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMMUCYST | 02194376 | Cancelled Post Market |
Medicinal ingredients
- BACILLUS CALMETTE-GUERIN BCG 81 MG per VIAL
- DILUENT 3 ML per VIAL